Showing 1-10 of about 32 articles.
ZELTIQ Aesthetics, Inc.
ZELTIQ(R) Announces Conference Call and Webcast of Fourth Quarter and Full Year 2012 Financial Results on March 12, 2013
PLEASANTON, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) -- ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its fourth quarter and full year 2012 financial results on Tuesday, March 12, 2013 after the market close.
ZELTIQ Aesthetics, Inc.
ZELTIQ(R) Aesthetics Announces Fourth Quarter 2012 Preliminary Unaudited Revenue
PLEASANTON, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) -- ZELTIQ Aesthetics, Inc. (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today preliminary unaudited estimated revenue for the fourth quarter 2012. ZELTIQ anticipates fourth quarter revenue of approximately $18 million. The quarterly numbers are prior to the completion of review and audit procedures by the Company's external auditors and are therefore subject to adjustment.
ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. to Present at the 31st Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to present at the 31
ZELTIQ Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
PLEASANTON, Calif., Nov. 28, 2012 (GLOBE NEWSWIRE) -- ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York, NY.
ZELTIQ Aesthetics, Inc.
ZELTIQ(R) Aesthetics Appoints Patrick F. Williams as Chief Financial Officer
PLEASANTON, Calif., Nov. 19, 2012 (GLOBE NEWSWIRE) -- ZELTIQ Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that it has further strengthened its management team with the appointment of Patrick F. Williams as Senior Vice President and Chief Financial Officer, effective immediately.
Showing 1-10 of about 32 articles.